For the twelve months ended Sep 30, 2026, CONMED Corporation reported $1.37B of revenue and $73.43M of net income.
CNMD revenueQ3 2026$335.56M
- Quarter YoY
- -0.7%
- QoQ
- -2.3%
- FY YoY
- +5.2%
- 5Y CAGR
- +9.8%
- 10Y CAGR
- +6.7%
CNMD revenue was $335.56M in fiscal Q3 2026 (ended Sep 30, 2026), down 0.7% from a year earlier and down 2.3% from the prior quarter. For the full fiscal 2025 it was $1.37B, up 5.2% from fiscal 2024. Compound annual growth was +9.8% over 5 years and +6.7% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
CNMD net incomeQ3 2026$19.80M
- Quarter YoY
- +592.4%
- QoQ
- -14.2%
- FY YoY
- -64.5%
- 5Y CAGR
- +37.7%
- 10Y CAGR
- +4.4%
CNMD net income was $19.80M in fiscal Q3 2026 (ended Sep 30, 2026), up 592.4% from a year earlier and down 14.2% from the prior quarter. For the full fiscal 2025 it was $47.05M, down 64.5% from fiscal 2024. Compound annual growth was +37.7% over 5 years and +4.4% over 10 years.
CNMD EPSQ3 2026$0.66
- Quarter YoY
- +633.3%
- QoQ
- -14.3%
- FY YoY
- -64.5%
- 5Y CAGR
- +36.4%
- 10Y CAGR
- +3.3%
CNMD diluted EPS was $0.66 in fiscal Q3 2026 (ended Sep 30, 2026), up 633.3% from a year earlier and down 14.3% from the prior quarter. For the full fiscal 2025 it was $1.51, down 64.5% from fiscal 2024. Compound annual growth was +36.4% over 5 years and +3.3% over 10 years.
CNMD free cash flowQ3 2026$46.73M
- Quarter YoY
- -3.7%
- FY YoY
- -2.0%
- 5Y CAGR
- +24.0%
- 10Y CAGR
- +15.4%
CNMD free cash flow was $46.73M in fiscal Q3 2026 (ended Sep 30, 2026), down 3.7% from a year earlier. For the full fiscal 2025 it was $150.88M, down 2.0% from fiscal 2024. Compound annual growth was +24.0% over 5 years and +15.4% over 10 years. It rose in 6 of the last 10 fiscal years.
Source: XBRL data CONMED Corporation files with the SEC, latest filing dated Oct 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.